246 related articles for article (PubMed ID: 18703983)
1. Trend in incidence of osteoporosis-related fractures among 40- to 69-year-old women: analysis of a large insurance claims database, 2000-2005.
Islam S; Liu Q; Chines A; Helzner E
Menopause; 2009; 16(1):77-83. PubMed ID: 18703983
[TBL] [Abstract][Full Text] [Related]
2. Association of grip strength change with menopausal bone loss and related fractures: a population-based follow-up study.
Sirola J; Rikkonen T; Tuppurainen M; Jurvelin JS; Kröger H
Calcif Tissue Int; 2006 Apr; 78(4):218-26. PubMed ID: 16604281
[TBL] [Abstract][Full Text] [Related]
3. Osteodensitometry in healthy postmenopausal women.
Prescrire Int; 2008 Apr; 17(94):68-72. PubMed ID: 18536138
[TBL] [Abstract][Full Text] [Related]
4. A claims database analysis of persistence with alendronate therapy and fracture risk in post-menopausal women with osteoporosis.
Gold DT; Martin BC; Frytak JR; Amonkar MM; Cosman F
Curr Med Res Opin; 2007 Mar; 23(3):585-94. PubMed ID: 17355739
[TBL] [Abstract][Full Text] [Related]
5. Bone mass measurement and factors associated with risk of fracture in a group of peri- and postmenoupausal women.
Rasheed A; Khurshid R; Aftab L
J Ayub Med Coll Abbottabad; 2008; 20(1):48-51. PubMed ID: 19024185
[TBL] [Abstract][Full Text] [Related]
6. Association between low lean body mass and osteoporotic fractures after menopause.
Capozza RF; Cure-Cure C; Cointry GR; Meta M; Cure P; Rittweger J; Ferretti JL
Menopause; 2008; 15(5):905-13. PubMed ID: 18520697
[TBL] [Abstract][Full Text] [Related]
7. Patterns of hormone replacement therapy in a population-based cohort of postmenopausal German women. Changes after HERS II and WHI.
Clanget C; Hinke V; Lange S; Fricke R; Botko R; Pfeilschifter J
Exp Clin Endocrinol Diabetes; 2005 Oct; 113(9):529-33. PubMed ID: 16235155
[TBL] [Abstract][Full Text] [Related]
8. Rationale for using raloxifene to prevent both osteoporosis and breast cancer in postmenopausal women.
Lee WL; Chao HT; Cheng MH; Wang PH
Maturitas; 2008 Jun; 60(2):92-107. PubMed ID: 18534794
[TBL] [Abstract][Full Text] [Related]
9. Prior oral contraception and postmenopausal fracture: a Women's Health Initiative observational cohort study.
Barad D; Kooperberg C; Wactawski-Wende J; Liu J; Hendrix SL; Watts NB
Fertil Steril; 2005 Aug; 84(2):374-83. PubMed ID: 16084878
[TBL] [Abstract][Full Text] [Related]
10. The WHI: the effect of hormone replacement therapy on fracture prevention.
de Villiers TJ; Stevenson JC
Climacteric; 2012 Jun; 15(3):263-6. PubMed ID: 22612613
[TBL] [Abstract][Full Text] [Related]
11. Estrogen receptor alpha and beta polymorphisms: is there an association with bone mineral density, plasma lipids, and response to postmenopausal hormone therapy?
Silvestri S; Thomsen AB; Gozzini A; Bagger Y; Christiansen C; Brandi ML
Menopause; 2006; 13(3):451-61. PubMed ID: 16735942
[TBL] [Abstract][Full Text] [Related]
12. [Evidence of hormone replacement therapy for osteoporosis].
Tarakida A; Higuchi T; Mizunuma H
Clin Calcium; 2008 Oct; 18(10):1434-41. PubMed ID: 18830040
[TBL] [Abstract][Full Text] [Related]
13. Alternate options to hormone replacement therapy for osteoporosis.
Shoemaker JR; Klemes AB
J Am Osteopath Assoc; 2003 Oct; 103(10 Suppl 6):S1-5. PubMed ID: 14620078
[TBL] [Abstract][Full Text] [Related]
14. Women's health. Osteoporosis.
Metules T
RN; 2003 Nov; 66(11):56-62; quiz 64. PubMed ID: 14685998
[No Abstract] [Full Text] [Related]
15. Effect of the Women's Health Initiative on osteoporosis therapy and expenditure in Medicaid.
Udell JA; Fischer MA; Brookhart MA; Solomon DH; Choudhry NK
J Bone Miner Res; 2006 May; 21(5):765-71. PubMed ID: 16734392
[TBL] [Abstract][Full Text] [Related]
16. [Prevention of osteoporosis and its economic aspects].
Blachier C
Cah Sociol Demogr Med; 1999; 39(2-3):271-82. PubMed ID: 10615567
[TBL] [Abstract][Full Text] [Related]
17. Loop diuretic use and fracture in postmenopausal women: findings from the Women's Health Initiative.
Carbone LD; Johnson KC; Bush AJ; Robbins J; Larson JC; Thomas A; LaCroix AZ
Arch Intern Med; 2009 Jan; 169(2):132-40. PubMed ID: 19171809
[TBL] [Abstract][Full Text] [Related]
18. Bisphosphonate dose and incidence of fractures in postmenopausal osteoporosis.
Makras P; Hamdy NA; Zwinderman AH; Ballieux BE; Papapoulos SE
Bone; 2009 May; 44(5):766-71. PubMed ID: 19442613
[TBL] [Abstract][Full Text] [Related]
19. [Fracture incidence in 803 women with postmenopausal osteoporosis under drug treatment].
Cronenberg A; Minkus A; Bremer G; Keck E
Z Orthop Ihre Grenzgeb; 1993; 131(1):70-4. PubMed ID: 8480444
[TBL] [Abstract][Full Text] [Related]
20. Invited Commentary: Hormone therapy risks and benefits--The Women's Health Initiative findings and the postmenopausal estrogen timing hypothesis.
Banks E; Canfell K
Am J Epidemiol; 2009 Jul; 170(1):24-8. PubMed ID: 19468078
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
